Predictive Oncology

2:45 PM - 3:00 PM (EDT), Monday, June 5, 2023 ・ Session Room 103
Predictive Oncology is a knowledge-driven company disrupting the oncology drug discovery paradigm to increase the probability of success of drug candidates during clinical development. The goal is to help biopharma develop the right therapy for the right patient leading to more effective treatments and improved patient outcomes. Powered by AI, Predictive Oncology leverages a biobank of 150,000+ cancer tumors, categorized by patient type, to predict drug response in a heterogeneous population against early stage drug compounds. The outcome enables partners to increase the probability of success of drug candidates in clinical trials and narrow down the tumor indications to be most likely to succeed.
Company Type:
Publicly Traded Company
Company HQ State:
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Placeholder Photo
Chief Business Officer
Predictive Oncology